Share-based Payment Arrangement, Expense of ImageneBio, Inc. from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ImageneBio, Inc. annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2020 to 31 Dec 2025.
  • ImageneBio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 25 Jul 2025 was $14,000,000, a 995% increase year-over-year.
  • ImageneBio, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $15,391,000.
  • ImageneBio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $0, a 100% decline from 2023.
  • ImageneBio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7,632,000, a 1.4% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

ImageneBio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,391,000 +$15,391,000 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $0 -$7,632,000 -100% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $7,632,000 +$107,000 +1.4% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $7,525,000 +$2,348,000 +45% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $5,177,000 +$3,380,000 +188% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023 2022 FY
2020 $1,797,000 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY

ImageneBio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $14,000,000 +$12,721,000 +995% 25 Jul 2025 10-K 10 Mar 2026 2025 FY
Q2 2025 $458,000 -$821,000 -64% 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 $904,000 -$1,097,000 -55% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,297,000 -$6,052,000 -345% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $1,017,000 -$981,000 -49% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,279,000 -$600,000 -32% 30 Jun 2024 10-Q 24 Jul 2025 2025 Q2
Q1 2024 $2,001,000 +$1,000 +0.05% 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $1,755,000 -$104,000 -5.6% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $1,998,000 +$187,000 +10% 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $1,879,000 -$76,000 -3.9% 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,000,000 +$100,000 +5.3% 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $1,859,000 +$278,000 +18% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $1,811,000 +$362,000 +25% 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $1,955,000 +$693,000 +55% 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,900,000 +$1,015,000 +115% 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $1,581,000 +$931,000 +143% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $1,449,000 +$1,031,000 +247% 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $1,262,000 +$908,000 +256% 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $885,000 +$510,000 +136% 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $650,000 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $418,000 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $354,000 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $375,000 31 Mar 2020 10-Q 13 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.